Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. Leite MI. Neurology 2021;96:294-295.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leite MI. Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. Neurology 2021;96:294-295.
PMID: 33558402